摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

allyl 2-acetamido-2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl)-β-D-glucopyranoside | 131338-01-7

中文名称
——
中文别名
——
英文名称
allyl 2-acetamido-2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl)-β-D-glucopyranoside
英文别名
allyl 2-acetamido-2-deoxy-3,4-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D-glucopyranoside;Allyl 2-acetamido-2-deoxy-3,4-O-(1,1,3,3-tetraisoproypldisiloxan-1,3-diyl)-β-D-glucopyranoside;allyl 2-acetamido-2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-glucopyranoside;N-[(5aR,6R,8R,9R,9aR)-6-(hydroxymethyl)-2,2,4,4-tetra(propan-2-yl)-8-prop-2-enoxy-6,8,9,9a-tetrahydro-5aH-pyrano[3,4-f][1,3,5,2,4]trioxadisilepin-9-yl]acetamide
allyl 2-acetamido-2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl)-β-D-glucopyranoside化学式
CAS
131338-01-7
化学式
C23H45NO7Si2
mdl
——
分子量
503.784
InChiKey
AEXGRHSHDLEHAB-GNJRFXKQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.74
  • 重原子数:
    33.0
  • 可旋转键数:
    9.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    95.48
  • 氢给体数:
    2.0
  • 氢受体数:
    7.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of allyl O-[sodium (α-d-glcero-d-talo-2-octulopyranosyl)onate]-(2 → 6)-2-acetamido-2-deoxy-β-d-glucopyranoside, a core constituent of the lipopolysaccharide from Acinetobacter calcoaceticus NCTC 10305
    作者:Josef Gass、Martina Strobl、Andreas Loibner、Paul Kosma、Ulrich Zähringer
    DOI:10.1016/0008-6215(93)80005-y
    日期:1993.5
    Abstract Reaction of methyl 2,6-anhydro-2,3-dideoxy- d -manno-2-octenoate 1 with 3-chloroperoxybenzoic acid gave the 2,3-anhydro derivative 2, which was converted into the per-O-acetylated anomeric methyl glycosides of d -glycero- d -galacto-2-octulopyranosylonic acid in good yield. Subsequent inversion of the configuration at C-3 and deprotection afforded sodium (methyl β- d -glycero- d -talo-2-o
    摘要2,6-脱-2,3-二脱氧-d-甘露二-2-辛烯酸甲酯与3-过氧苯甲酸的反应生成2,3-脱生物2,将其转化为过-O-乙酰化的异头物d-甘油-d-半乳糖-2-辛基喃糖基磺酸的甲基糖苷收率良好。随后在C-3处反转构型并脱保护,得到(甲基β-d-甘油-d-talo-2-辛基葡萄糖苷)磺酸钠。备选地,将2转化成(α-d-甘油-d-talo-2-辛基喃糖基化)甲基丙烯酸酯衍生物。由三氟甲磺酸促进的与甲醇或烯丙基2-乙酰基-2-脱氧-3,4-O-(1,1,3,3-四异丙基二硅氧烷-1,3-二基)-β-d-葡萄糖苷的反应得到良好的相应原酸酯衍生物的产率。
  • Synthesis of neoglycoproteins containing L-glycero-α-D- manno-heptopyranosyl-(1→4)- and -(1→5)-linked 3-deoxy-α-D-manno-oct-2- ulopyranosylonic acid (Kdo) phosphate determinants
    作者:Harald Sekljic、Norbert Wimmer、Andreas Hofinger、Helmut Brade、Paul Kosma
    DOI:10.1039/a700497d
    日期:——
    The disaccharide allyl glycosides 4, 8, 13 and the trisaccharide 33 have been prepared using heptopyranosyl trichloroacetimidate 1 or the disaccharide bromide 27 as glycosyl donors followed by efficient O-phosphorylation via the amidite procedure. The allyl glycosides 4, 8 and 33 are converted into 3-(2-aminoethylthio)propyl glycosides and are coupled to bovine serum albumin. The resulting neoglycoconjugates 6 and 35 containing spacer-linked Hep-(1→4)-Kdo and Hep-(1→5)-Kdo 4-phosphate-(2→6)-β-GlcNAc residues correspond to part structures of the inner core region in bacterial lipopolysaccharide, whereas compound 10 contains the artificial analogue Hep-(1→4)-Kdo 5-phosphate. The compounds may be used in immunochemical characterisation of monoclonal antibodies.
    使用庚喃糖基三乙酰亚酸 1 或双糖化物 27 作为糖基供体,然后通过脒基程序进行有效的 O-磷酸化,制备出了双糖烯丙基糖苷 4、8、13 和三糖 33。烯丙基苷 4、8 和 33 转化为 3-(2-基乙基)丙基苷,并与牛血清白蛋白偶联。由此制得的新糖苷结合物 6 和 35 含有间隔连接的 Hep-(1â4)-Kdo 和 Hep-(1â5)-Kdo 4-磷酸-(2â6)-δ²-GlcNAc 残基,与细菌脂多糖内核区的部分结构相对应,而化合物 10 则含有人工类似物 Hep-(1â4)-Kdo 5-磷酸。这些化合物可用于单克隆抗体的免疫化学鉴定。
  • Synthesis of 5-Thio-<scp>l</scp>-fucose-Containing Disaccharides, as Sequence-Specific Inhibitors, and 2‘-Fucosyllactose, as a Substrate of α-<scp>l</scp>-Fucosidases
    作者:Masayuki Izumi、Osamu Tsuruta、Satoru Harayama、Hironobu Hashimoto
    DOI:10.1021/jo961725h
    日期:1997.2.1
    Four 5-thio-L-fucose-containing disaccharides having alpha(1-->6), alpha(1-->3), alpha(1-->4)GlcNAc, and alpha(1-->2-Gal linkages (compounds 1-4, respectively) were synthesized as potential alpha-L-fucosidase inhibitors. The glycosylation reactions using 2,3,4-tri-O-acetyl-5-thio-L-fucopyranosyl trichloroacetimidate as a glycosyl donor and BF3 . OEt(2) as a catalyst gave mainly alpha-linked disaccharides. Only alpha(1-->2)-linked disaccharide 4 showed inhibitory activity (K-i = 0.21 mM) against Bacillus alpha-L-fucosidase which hydrolyzes the Fuc alpha(1-->2) linkage specifically. The results suggested that sequence specificity of an enzyme could be estimated from the inhibitory activities of the compounds 1-4. In contrast, every disaccharide showed inhibitory activity (K-i = 30-91 mu M) against bovine epididymis alpha-L-fucosidase.
  • Short synthesis of allyl 2-acetamido-2-deoxy-3,6-di-O-(α-l-fucopyranosyl)-β-d-glucopyranoside
    作者:Christian Steindl、Paul Kosma、Leopold März、András Neszmélyi
    DOI:10.1016/0008-6215(93)84047-a
    日期:1993.8
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)